10q22.3q23.3 microduplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:276422Q92.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

10q22.3q23.3 microduplication syndrome (Orphanet: 276422) is a rare chromosomal anomaly caused by a duplication of genetic material on the long arm of chromosome 10, specifically in the 10q22.3 to 10q23.3 region. This region encompasses several genes, including BMPR1A and PTEN, which play important roles in cell growth and development. The syndrome is characterized by variable clinical features that can affect multiple body systems. Key clinical features reported in affected individuals include intellectual disability of variable severity, developmental delay (particularly speech and motor delays), behavioral abnormalities, and dysmorphic facial features. Facial features may include a broad forehead, hypertelorism, a flat nasal bridge, and low-set ears. Some patients may also present with growth abnormalities, hypotonia (reduced muscle tone), and skeletal anomalies. Congenital malformations affecting the heart and other organ systems have been described in some cases, though the phenotype is highly variable even among individuals carrying similar duplications. There is no specific cure or targeted therapy for 10q22.3q23.3 microduplication syndrome. Management is supportive and symptom-based, involving early intervention programs, speech therapy, occupational therapy, physical therapy, and special educational support. Regular developmental assessments and monitoring for associated complications are recommended. Genetic counseling is important for affected families to understand recurrence risks and the variable expressivity of this condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of the philtrumHP:0000288
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 10q22.3q23.3 microduplication syndrome.

View clinical trials →

No actively recruiting trials found for 10q22.3q23.3 microduplication syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 10q22.3q23.3 microduplication syndrome community →

No specialists are currently listed for 10q22.3q23.3 microduplication syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 10q22.3q23.3 microduplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 10q22.3q23.3 microduplication syndromeForum →

No community posts yet. Be the first to share your experience with 10q22.3q23.3 microduplication syndrome.

Start the conversation →

Latest news about 10q22.3q23.3 microduplication syndrome

No recent news articles for 10q22.3q23.3 microduplication syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 10q22.3q23.3 microduplication syndrome

What is 10q22.3q23.3 microduplication syndrome?

10q22.3q23.3 microduplication syndrome (Orphanet: 276422) is a rare chromosomal anomaly caused by a duplication of genetic material on the long arm of chromosome 10, specifically in the 10q22.3 to 10q23.3 region. This region encompasses several genes, including BMPR1A and PTEN, which play important roles in cell growth and development. The syndrome is characterized by variable clinical features that can affect multiple body systems. Key clinical features reported in affected individuals include intellectual disability of variable severity, developmental delay (particularly speech and motor de

How is 10q22.3q23.3 microduplication syndrome inherited?

10q22.3q23.3 microduplication syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does 10q22.3q23.3 microduplication syndrome typically begin?

Typical onset of 10q22.3q23.3 microduplication syndrome is neonatal. Age of onset can vary across affected individuals.